Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dendritic cells in experimental allergic encephalomyelitis and multiple sclerosis.

H Link1, Y M Huang, B G Xiao

  • 1Karolinska Institute, Division of Neurology, Huddinge University Hospital, Stockholm, Sweden.

Journal of Neuroimmunology
|March 1, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A putative mechanism on remission of multiple sclerosis during pregnancy: estrogen-induced indoleamine 2,3-dioxygenase by dendritic cells.

Multiple sclerosis (Houndmills, Basingstoke, England)·2007
Same author

Immunopathogenesis and prevention of uveitis with the Behçet's disease-specific peptide linked to cholera toxin B.

Advances in experimental medicine and biology·2003
Same author

Rat models as tool to develop new immunotherapies.

Immunological reviews·2002
Same author

Bone marrow-derived dendritic cells from experimental allergic encephalomyelitis induce immune tolerance to EAE in Lewis rats.

Clinical and experimental immunology·2001
Same author

Altered phenotype and function of blood dendritic cells in multiple sclerosis are modulated by IFN-beta and IL-10.

Clinical and experimental immunology·2001
Same author

Effects of Linomide on immune cells and cytokines inhibit autoimmune pathologies of the central and peripheral nervous system.

International immunopharmacology·2001

Dendritic cells (DC) can trigger autoimmune diseases by activating self-reactive T cells. Modulating these cells towards a tolerogenic state offers a potential new therapy for conditions like multiple sclerosis.

Area of Science:

  • Immunology
  • Autoimmunity
  • Cellular Biology

Background:

  • The precise mechanisms initiating autoimmune diseases and autoreactive T cell activation remain unclear.
  • Dendritic cells (DC), as potent antigen-presenting cells (APCs), play a crucial role in breaking self-tolerance and inducing autoimmune responses.
  • Different DC subsets differentially influence T helper cell (Th1/Th2) responses in autoimmune disease development.

Purpose of the Study:

  • To investigate the role of dendritic cells in the initiation and maintenance of autoimmune diseases.
  • To explore the potential of modulating dendritic cell function for therapeutic purposes.

Main Methods:

  • Analysis of dendritic cell subsets and their functions in autoimmune disease models.
  • Investigation of cytokine-mediated conversion of immunogenic to tolerogenic dendritic cells.

Related Experiment Videos

Main Results:

  • Dendritic cells are identified as key initiators of autoreactive T cell responses.
  • Specific cytokine treatments can transform immunogenic dendritic cells into tolerogenic ones.
  • Distinct dendritic cell types exhibit varied capacities for inducing Th1/Th2 responses.

Conclusions:

  • Dendritic cells are central players in the pathogenesis of autoimmune diseases.
  • Modulating dendritic cells to promote tolerance presents a promising therapeutic strategy.
  • This approach holds potential for treating multiple sclerosis and other autoimmune conditions.